Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Early treatment may help babies with spinal muscular atrophy sit without support

NCT ID NCT03779334

First seen Dec 11, 2025 · Last updated May 22, 2026 · Updated 22 times

Summary

This study tested a daily oral medicine called risdiplam in 26 infants who have a genetic diagnosis of spinal muscular atrophy (SMA) but do not yet show symptoms. The goal was to see if starting treatment early helps them reach motor milestones like sitting without support. Results showed that many infants achieved this milestone, suggesting early treatment may prevent or delay severe muscle weakness.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MUSCULAR ATROPHY, SPINAL are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Chr de La Citadelle

    Liège, 4000, Belgium

  • Hospital das Clinicas - FMUSP_X

    São Paulo, São Paulo, 05403-000, Brazil

  • Kaohsiung Medical University Chung-Ho Hospital

    Kaohsiung City, 807, Taiwan

  • Nemours Children's Hospital

    Orlando, Florida, 32837, United States

  • Russian Children Neuromuscular Center of Veltischev

    Moscow, Moscow Oblast, 125412, Russia

  • Sydney Children's Hospital

    Randwick, New South Wales, 2031, Australia

  • Szpital Gdanskiego Uniwersytetu Medycznego

    Gda?sk, 80-952, Poland

Conditions

Explore the condition pages connected to this study.